USA Change Macroaxis User Registration

Home Portfolios Solutions About Us

More ROI Blog

PortfoliosPositionsRebalanceAnalyzeOptimize Suggest Industries

US Market Closed: Feb 9, 17:42 PM 2012

NYSE 8081.25 1.73 Index Moved Down

NASDAQ 2927.23 11.37 Index Moved Up

and more..

sponsered by

Processing
Collecting necessary data for ADMP and CBRX...

Asset Comparison and Correlation

View All Portfolios

More Actions
- Select Assests
- Optimize Portfolio
- Suggest Portfolio
- Backtest Watchlist
- Analyze Correlations
- View Transactions
- Check Volatilities
- Import Equities
- Search Equities
- Filter Tops

Adamis Pharmaceuticl and

Columbia Laboratories Inc.

Volatility

Matrix

Run Correlation

Diversification

Average diversification

Overlapping area represents amount of risk that can be diversified away by holding Adamis Pharmaceuticl and Columbia Laboratories Inc. in the same portfolio (assuming nothing else is changed)

Optimize

Correlation Coefficient

0.13

Parameters

Time Period	1 Month [change]
Direction	Positive
Strength	Insignificant
Accuracy	85.19%
Values	Daily Returns

Suggest

Adamis Pharmaceuticl

Profile

0.17

Intraday

One Month

^0.00

0.00%

ADMP

OTCBB

Adamis Pharmaceuticl

Day Low	0.16	Open	0.16
Market Cap	15.8M	Volume	491032
Sector	Healthcare	Last Close	0.17
Last Traded	2/9/2012	Year High	Not Applicable
EBITDA	-6.8M	Year Low	Not Applicable
Book Value	-0.022	EPS	-0.076
Day High	0.179	Industry	Drug Delivery
Current EPS	-0.076	This Year EPS	Not Applicable

Columbia Laboratories Inc.

Profile

0.82

Intraday

One Month

^(0.04)

4.12%

CBRX

NGM

Columbia Laboratories Inc.

P/E	5.48	Day Low	0.815
Open	0.84	P/B Ratio	3.44
Market Cap	71.1M	Volume	671103
Sector	Healthcare	Last Close	0.85
Short Ratio	9.00	Last Traded	2/9/2012
Year High	4.31	Percent Change	4.12%
EBITDA	-1.3M	Year Low	0.64
Absolute Change	0.04	Time	Not Applicable
Book Value	0.247	EPS	0.155
Employees	22	Day High	0.85
Target Price	1.50	Current EPS	0.155
This Year EPS	0.05	Next Year EPS	0.05
Current PE	5.48	This Year PE	17.00
Next Year PE	17.00	Dividend	Not Applicable